DLC1 antibody (N-Term)
-
- Target See all DLC1 Antibodies
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
-
Binding Specificity
- N-Term
-
Reactivity
- Human, Mouse
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This DLC1 antibody is un-conjugated
-
Application
- Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Purpose
- DLC1 (Isoforms 1 and 3)
- Sequence
- SVAIRKRSWE EHC
- Specificity
- This antibody is expected to recognise isoforms 1 and 3 ( NP_872584.2 and NP_079043.3 resp) but NOT isoform 2 (NP_006085.2).
- Cross-Reactivity
- Human, Mouse, Pig
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Grade
- Verified
- Immunogen
- Peptide with sequence SVAIRKRSWEEHC, from the N Terminus of the protein sequence according to NP_872584.2, NP_079043.3.
- Isotype
- IgG
-
-
- Application Notes
-
Immunohistochemistry: Paraffin embedded Mouse Adrenal Gland. Recommended concentration: 4 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:64000.
- Comment
-
Immunofluorescence: Expression of the protein seen in the cytoplasm and nucleus of U251 and U2OS cells. Recommended concentration: 10μg/ml.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 30, Issue 1, pp. 139-48, (2009) (PubMed).
: "
-
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 30, Issue 1, pp. 139-48, (2009) (PubMed).
-
- Target
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
- Alternative Name
- DLC1 (DLC1 Products)
- Synonyms
- ARHGAP7 antibody, HP antibody, STARD12 antibody, p122-RhoGAP antibody, rhogap7 antibody, DLC-1 antibody, StARD12 antibody, Dlc-1 antibody, A730069N07Rik antibody, Arhgap7 antibody, dlc-1 antibody, RhoGAP antibody, Dlc1 antibody, DLC1 Rho GTPase activating protein antibody, DLC1 Rho GTPase activating protein S homeolog antibody, rho GTPase-activating protein 7 antibody, deleted in liver cancer 1 antibody, DLC1 antibody, dlc1.S antibody, dlc1 antibody, LOC100456847 antibody, Dlc1 antibody, LOC100729904 antibody
- Background
- DLC1, HP, ARHGAP7, STARD12, FLJ21120, p122-RhoGAP, deleted in liver cancer 1, Rho-GTPase-activating protein 7, START domain containing protein 12, StAR-related lipid, transfer protein 12, StAR-related lipid transfer (START) domain containing 12, deleted
- Gene ID
- 10395, 50768
- NCBI Accession
- NP_872584, NP_079043
- Pathways
- Tube Formation, Positive Regulation of Endopeptidase Activity
-